NCT05605522 2025-08-24A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours3B Pharmaceuticals GmbHPhase 1 Terminated19 enrolled
NCT05061537 2024-04-12Study of PF-07263689 in Participants With Selected Advanced Solid TumorsPfizerPhase 1 Terminated13 enrolled 16 charts
NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT02890368 2023-04-05Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis FungoidesPfizerPhase 1 Terminated56 enrolled
NCT03906526 2023-02-24A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck CancerCelgenePhase 1 Terminated15 enrolled
NCT02437916 2022-11-08Safety Study of AMG 228 to Treat Solid TumorsAmgenPhase 1 Terminated30 enrolled
NCT02438995 2021-11-03Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and NeckNorthwell HealthPhase 1 Terminated11 enrolled
NCT01871311 2019-02-08A Phase I Study of Nilontinib and Cetuximab in Patients With Solid TumorsGeorgetown UniversityPhase 1 Terminated15 enrolled
NCT02205398 2019-01-22Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab TherapyNovartisPhase 1 Terminated13 enrolled
NCT01963715 2015-10-02A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid TumorsImmunoGen, Inc.Phase 1 Terminated20 enrolled
NCT02254044 2014-10-01Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or EsophagusBoehringer IngelheimPhase 1 Terminated7 enrolled
NCT00368329 2012-07-16Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal CancerStanford UniversityPhase 1 Terminated4 enrolled